<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/C/Carboplatin.html">
<title>Carboplatin RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/C/Carboplatin.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2012-02-09T09:45+50:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Carboplatin RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/MDLinx/statuses/167591263791620096" />
  <rdf:li rdf:resource="http://twitter.com/ShaJohOne/statuses/167386203648303104" />
  <rdf:li rdf:resource="http://twitter.com/spacemanoveramk/statuses/167221137825210368" />
  <rdf:li rdf:resource="http://twitter.com/foplipo/statuses/167218103007199232" />
  <rdf:li rdf:resource="http://twitter.com/TheSmartestOnc/statuses/167196187332587520" />
  <rdf:li rdf:resource="http://twitter.com/dmleotod9/statuses/167097901963685888" />
  <rdf:li rdf:resource="http://twitter.com/quequesierra/statuses/166977212896124928" />
  <rdf:li rdf:resource="http://twitter.com/Massalcolombia/statuses/166941733710598144" />
  <rdf:li rdf:resource="http://twitter.com/ugcfarmacg/statuses/166810009634750464" />
  <rdf:li rdf:resource="http://twitter.com/TheSmartestOnc/statuses/166806244542255105" />
  <rdf:li rdf:resource="http://twitter.com/eMediWrite/statuses/166409806209490946" />
  <rdf:li rdf:resource="http://twitter.com/eMediWrite/statuses/166409420471930881" />
  <rdf:li rdf:resource="http://twitter.com/DrNordquist/statuses/165584496249413632" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/MDLinx/statuses/167591263791620096">
<title>Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic ... http://t.co/aTCPDvGd #oncology</title>
<link>http://twitter.com/MDLinx/statuses/167591263791620096</link>
<description><![CDATA[Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic ... http://t.co/aTCPDvGd #oncology]]></description>
</item>

<item rdf:about="http://twitter.com/ShaJohOne/statuses/167386203648303104">
<title>CSU- Metronomic cyclophosphamide combined with carboplatin for ...</title>
<link>http://twitter.com/ShaJohOne/statuses/167386203648303104</link>
<description><![CDATA[CSU- Metronomic cyclophosphamide combined with carboplatin for ...]]></description>
</item>

<item rdf:about="http://twitter.com/spacemanoveramk/statuses/167221137825210368">
<title>Hope that &#x27;Carboplatin&#x27; (new chemo drug) is manageable for mom. She&#x27;s first time handling &#x27;shortness of breath&#x27; as a delayed side effect.</title>
<link>http://twitter.com/spacemanoveramk/statuses/167221137825210368</link>
<description><![CDATA[Hope that 'Carboplatin' (new chemo drug) is manageable for mom. She's first time handling 'shortness of breath' as a delayed side effect.]]></description>
</item>

<item rdf:about="http://twitter.com/foplipo/statuses/167218103007199232">
<title>&#xE3;&#x82;&#xAB;&#xE3;&#x83;&#xAB;&#xE3;&#x83;&#x9C;&#xE3;&#x83;&#x97;&#xE3;&#x83;&#xA9;&#xE3;&#x83;&#x81;&#xE3;&#x83;&#xB3; http://t.co/vhFD8eb4 #Carboplatin</title>
<link>http://twitter.com/foplipo/statuses/167218103007199232</link>
<description><![CDATA[カルボプラチン http://t.co/vhFD8eb4 #Carboplatin]]></description>
</item>

<item rdf:about="http://twitter.com/TheSmartestOnc/statuses/167196187332587520">
<title>A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small ... http://t.co/OQZXRZzZ #ThoracicCancer</title>
<link>http://twitter.com/TheSmartestOnc/statuses/167196187332587520</link>
<description><![CDATA[A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small ... http://t.co/OQZXRZzZ #ThoracicCancer]]></description>
</item>

<item rdf:about="http://twitter.com/dmleotod9/statuses/167097901963685888">
<title>Cyclophophamide / Ifosfamide / Cisplatin / Oxaliplatin / Carboplatin</title>
<link>http://twitter.com/dmleotod9/statuses/167097901963685888</link>
<description><![CDATA[Cyclophophamide / Ifosfamide / Cisplatin / Oxaliplatin / Carboplatin]]></description>
</item>

<item rdf:about="http://twitter.com/quequesierra/statuses/166977212896124928">
<title>RT @ugcfarmacg: (JCO)Addition of thalidomide to paclitaxel and carboplatin shows no benefit in patients with NSCLC http://t.co/9jQxjQla</title>
<link>http://twitter.com/quequesierra/statuses/166977212896124928</link>
<description><![CDATA[RT @ugcfarmacg: (JCO)Addition of thalidomide to paclitaxel and carboplatin shows no benefit in patients with NSCLC http://t.co/9jQxjQla]]></description>
</item>

<item rdf:about="http://twitter.com/Massalcolombia/statuses/166941733710598144">
<title>Phase II St Carboplatin +- Bevaciz+Neoadjuvant Paclitaxel and D-D Doxo/Cyclophosph Triple-Negative Resectable Breast Ca http://t.co/zqm6ZtHl</title>
<link>http://twitter.com/Massalcolombia/statuses/166941733710598144</link>
<description><![CDATA[Phase II St Carboplatin +- Bevaciz+Neoadjuvant Paclitaxel and D-D Doxo/Cyclophosph Triple-Negative Resectable Breast Ca http://t.co/zqm6ZtHl]]></description>
</item>

<item rdf:about="http://twitter.com/ugcfarmacg/statuses/166810009634750464">
<title>(JCO)Addition of thalidomide to paclitaxel and carboplatin shows no benefit in patients with NSCLC http://t.co/9jQxjQla</title>
<link>http://twitter.com/ugcfarmacg/statuses/166810009634750464</link>
<description><![CDATA[(JCO)Addition of thalidomide to paclitaxel and carboplatin shows no benefit in patients with NSCLC http://t.co/9jQxjQla]]></description>
</item>

<item rdf:about="http://twitter.com/TheSmartestOnc/statuses/166806244542255105">
<title>RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-tre... http://t.co/dNW3swlR #ThoracicCancer</title>
<link>http://twitter.com/TheSmartestOnc/statuses/166806244542255105</link>
<description><![CDATA[RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-tre... http://t.co/dNW3swlR #ThoracicCancer]]></description>
</item>

<item rdf:about="http://twitter.com/eMediWrite/statuses/166409806209490946">
<title>A risk-adapted strgy of adj paclitaxel/carboplatin in early-stage ovarian ca: Time-dependent effect of 4 vs 6 cycles  http://t.co/Um4qMVfg</title>
<link>http://twitter.com/eMediWrite/statuses/166409806209490946</link>
<description><![CDATA[A risk-adapted strgy of adj paclitaxel/carboplatin in early-stage ovarian ca: Time-dependent effect of 4 vs 6 cycles  http://t.co/Um4qMVfg]]></description>
</item>

<item rdf:about="http://twitter.com/eMediWrite/statuses/166409420471930881">
<title>Oncology Medical Article | A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: T&#xE2;&#x80;&#xA6;http://t.co/Ctx2ryWI</title>
<link>http://twitter.com/eMediWrite/statuses/166409420471930881</link>
<description><![CDATA[Oncology Medical Article | A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: T…http://t.co/Ctx2ryWI]]></description>
</item>

<item rdf:about="http://twitter.com/DrNordquist/statuses/165584496249413632">
<title>ASCO #GU12 Stage I Seminoma: 3 options: Radiation, Carboplatin, growing support for Surveillance but risk of late recurrence.</title>
<link>http://twitter.com/DrNordquist/statuses/165584496249413632</link>
<description><![CDATA[ASCO #GU12 Stage I Seminoma: 3 options: Radiation, Carboplatin, growing support for Surveillance but risk of late recurrence.]]></description>
</item>

</rdf:RDF>
